XML 83 R52.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Financial Instruments (Tables)
12 Months Ended
Mar. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Derivative Instruments Outstanding
As of March 31, 2024, the Company had the following outstanding forward foreign exchange contracts (all outstanding contracts have maturities of less than 25 months from March 31, 2024):
March 31, 2024
Foreign CurrencyForeign Currency AmountUS Dollar AmountWeighted Average Exchange Rate Per $1 USD
 (Amounts in millions)(Amounts in millions)
British Pound Sterling0.5 GBPin exchange for$0.6 0.79 GBP
Czech Koruna180.0 CZKin exchange for$7.7 23.29 CZK
Euro0.6 EURin exchange for$0.5 0.91 EUR
Canadian Dollar21.4 CADin exchange for$15.9 1.34 CAD
Mexican Peso56.7 MXNin exchange for$3.0 18.95 MXN
Hungarian Forint1,450.0 HUFin exchange for$4.0 360.17 HUF
New Zealand Dollar$73.9  NZDin exchange for$45.3 1.64  NZD
Designated Cash Flow Hedges. As of March 31, 2024 and March 31, 2023, the Company had the following pay-fixed interest rate swaps, which have been designated as cash flow hedges outstanding (all related to the Company's SOFR-based debt, see Note 7 and Note 8):
Effective DateNotional AmountFixed Rate PaidMaturity Date
(in millions)
May 23, 2018$300.0 2.915%March 24, 2025
May 23, 2018$700.0 2.915%March 24, 2025
(1)
June 25, 2018$200.0 2.723%March 23, 2025
(1)
July 31, 2018$300.0 2.885%March 23, 2025
(1)
December 24, 2018$50.0 2.744%March 23, 2025
(1)
December 24, 2018$100.0 2.808%March 23, 2025
(1)
December 24, 2018$50.0 2.728%March 23, 2025
(1)
Total$1,700.0 
__________________
(1)Represents the re-designated swaps as described in the May 2022 Transactions section below that were previously not designated cash flow hedges at March 31, 2022.
Schedule of Derivative Instruments, Effect on Statements of Operations And Comprehensive Income The following table presents the pre-tax effect of the Company's derivatives on the accompanying consolidated statements of operations and comprehensive income (loss) for the years ended March 31, 2024, 2023 and 2022:
Year Ended
March 31,
202420232022
 (Amounts in millions)
Derivatives designated as cash flow hedges:
Forward exchange contracts
Gain (loss) recognized in accumulated other comprehensive income (loss)$(5.8)$1.7 $1.7 
Gain (loss) reclassified from accumulated other comprehensive income (loss) into direct operating expense(0.3)(0.3)(0.2)
Interest rate swaps
Gain recognized in accumulated other comprehensive income (loss)$36.3 $81.1 $66.5 
Gain (loss) reclassified from accumulated other comprehensive income (loss) into interest expense41.8 1.4 (15.0)
Derivatives not designated as cash flow hedges:
Interest rate swaps
Loss reclassified from accumulated other comprehensive income (loss) into interest expense$(7.2)$(11.8)$(33.8)
Total direct operating expense on consolidated statements of operations$2,189.2 $2,312.5 $2,064.2 
Total interest expense on consolidated statements of operations$269.8 $221.2 $176.0 
Derivative Instruments by Balance Sheet Location
As of March 31, 2024 and 2023, the Company had the following amounts recorded in the accompanying consolidated balance sheets related to the Company's use of derivatives:
March 31, 2024
Other Current AssetsOther Non-Current AssetsOther Accrued Liabilities
 (Amounts in millions)
Derivatives designated as cash flow hedges:
Forward exchange contracts$— $— $2.8 
Interest rate swaps35.6 — — 
Fair value of derivatives$35.6 $— $2.8 


March 31, 2023
Other Current AssetsOther Non-Current AssetsOther Accrued Liabilities
 (Amounts in millions)
Derivatives designated as cash flow hedges:
Forward exchange contracts$2.9 $— $0.1 
Interest rate swaps— 41.1 — 
Fair value of derivatives$2.9 $41.1 $0.1